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Abstract
Background: Greater adiposity is an important risk factor for nonalcoholic fatty liver disease (NAFLD). Thus, it is likely that
dietary intake is involved in the development of the disease. Prospective studies assessing the relation between childhood
dietary intake and risk of NAFLD are lacking.
Objective: This study was designed to explore associations between energy, carbohydrate, sugar, starch, protein,
monounsaturated fat, polyunsaturated fat, saturated fat, and total fat intake by youth at ages 3, 7, and 13 y and subsequent
(mean age: 17.8 y) ultrasound scan (USS)–measured liver fat and stiffness and serum alanine aminotransferase, aspartate
aminotransferase, and g-glutamyltransferase. We assessed whether observed associations were mediated through fat
mass at the time of outcome assessment.
Methods: Participants were from the Avon Longitudinal Study of Parents and Children. Trajectories of energy and macronutrient
intake fromages3–13 ywereobtainedwith linear-splinemultilevelmodels. Linear and logistic regressionmodels examinedwhether
energy intake and absolute and energy-adjusted macronutrient intake at ages 3, 7, and 13 y were associated with liver outcomes.
Results: Energy intake at all ageswas positively associatedwith liver outcomes; for example, the odds of having aUSS-measured
liver fat per 100 kcal increase in energy intake at age 3 y were 1.79 (95% CI: 1.14, 2.79). Associations between absolute
macronutrient intake and liver outcomeswere inconsistent and attenuated to the null after adjustment for total energy intake. The
majority of associations attenuated to the null after adjustment for fat mass at the time liver outcomes were assessed.
Conclusion: Higher childhood and early adolescent energy intake is associated with greater NAFLD risk, and the
macronutrients fromwhich energy intake is derived are less important. These associations appear to be mediated, at least
in part, by fat mass at the time of outcome assessment. J Nutr 2015;145:983–9.
Keywords: diet, energy intake, childhood, NAFLD, fatty liver
Introduction
Nonalcoholic fatty liver disease (NAFLD)9 is a common cause of
chronic liver disease in children and adolescents (1), and is asso-
ciated with fibrosis, insulin resistance, and dyslipidemia, inde-
pendently of total body fat (2). Because greater adiposity is a key
risk factor for NAFLD (3), it is likely that dietary intake is
involved in its development. Greater overall energy intake may
increase total body fatness, elevating the risk of fat infiltration into
the liver by increasing FFA influx from either the diet or via adipose
tissue to the liver, with a consequent increase in insulin resistance
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(3, 4). Alternatively, diet may affect the liver independently of body
fatness; studies have shown that manipulation of macro- and
micronutrient intake affects inflammation, serum lipids, and
insulin resistance, independently of weight loss (5–7).
Most existing evidence for an association between dietary
intake and NAFLD in children and adolescents comes from
cross-sectional studies (8–12). Results from these studies conflict
with some studies reporting that children with NAFLD have diets
high in refined carbohydrates (such as fructose) and SFAs and
low in PUFAs (8–10), and others reporting no differences in
energy or macronutrient intake between children with and
without NAFLD (9–11, 12). To our knowledge, just one study
has examined the prospective association between diet and
NAFLD in children and adolescents (13). This study identified
‘‘healthy’’ and ‘‘Western’’ dietary patterns and found that higher
Western dietary pattern scores at age 14 y were associated with
a greater risk of NAFLD at age 17 y. In the study, diet was
assessed with a single FFQ at age 14 y. Studies have found that
FFQs measure diet less accurately than food diaries. Moreover,
prospectively assessed repeatedmeasures of dietary intake, which
have not been used previously, are important for assessing the age
at which associations emerge and whether associations of dietary
intake with risk of NAFLD are specific to, or stronger at, a
particular age. Thus, the primary objective of this study was to
determine prospective associations between childhood energy
intake and markers of NAFLD [ultrasound scan (USS)–determined
liver fat and stiffness and blood-based indicators of liver
function, alanine aminotransferase (ALT), aspartate aminotrans-
ferase (AST), and g-glutamyltransferase (GGT)] assessed at mean
age 17.8 y, and to determine whether any observed associations
were mediated through total body fat at the time liver outcomes
were assessed. As a secondary objective, we explored whether
different macronutrients and their subgroups may be driving any
associations between energy intake and liver outcomes.
Methods
Study population
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a
prospective birth cohort from southwest England (14, 15). The study website
contains details of all data available through a fully searchable data dictionary
(http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary) (16).
Ethical approval for the study was obtained from the ALSPAC Law and
Ethics Committee and local research ethics committees. A total of 5081
participants attended the 17–18 y follow-up assessment at mean age 17.8 y.
Of these, n = 3188 (62.7%) had data available for ALT, AST, and/or GGT. A
liver USS substudy (n = 1887) was undertaken on a subgroup of participants
attending the 17–18 y follow-up (Supplemental Figure 1) (2). No participants
had a known history of jaundice or hepatitis, were taking medication that
would indicate hepatic disease, or were takingmedication known to influence
liver function.
Liver outcomes
Participants attending the morning clinic were instructed to fast
overnight, and those attending after lunch, for a minimum of 6 h.
Details of USS assessment in the ALSPAC have been published previ-
ously (2). Briefly, upper abdominal USS was completed by 1 of 4 trained
sonographers using a Siemens Acuson S2000 USS system. Echogenicity was
assessed and recorded as present, absent, or uncertain (17). Only 2 scans
(0.1%) in total were classified as uncertain. Levels of agreement in
identifying echogenicity between the 4 sonographers was 98% or greater,
both immediately after training and at 6 mo intervals throughout data
collection. Acoustic radiation force impulse imaging (acoustic radiation
force impulse measured as shear velocity in meters per second) of the right
lobe of the liver was used to measure liver stiffness (our indicator of liver
fibrosis) with the use of standard protocols (18).
Fasting blood samples were immediately centrifuged and frozen at
280C. Measurements were assayed within 3–9 mo after samples were
taken, with no previous freeze-thaw cycles. All assays were completed in
the same laboratory at the University of Glasgow. ALT, GGT, and AST
were measured by Roche Cobas automated analyzers (Roche Diagnos-
tics) with the use of enzymatic methods. All inter- and intra-CVs for these
blood-based assays were <5%.
Dietary intake from ages 3–13 y
Three-day food diaries were mailed to parents when study children were
aged 3.5, 5, 7, 10, and 13 y. Parents recorded their childs diet until the
child reached age 10 y. At age 10 y, children recorded their own diet with
help from their parents. Diaries were requested for 2 weekdays and
1 weekend day. FFQs were mailed to parents when study children were
aged 3, 4, 7, and 9 y. Full details of dietary intake assessment have been
published previously (19) and are in Supplemental Methods.
Covariables
Potential confounders considered included the following: maternal age
at delivery, parity, education, household social class, and prepregnancy
BMI; and participants age, sex, pubertal status, and physical activity
levels. Total fat mass and height at the time of outcome assessment were
considered as potential mediators. A full description of all measures is in
Supplemental Methods.
Eligibility criteria
Participants alcohol consumption was assessed at mean ages 16.7 y and
17.8 y with the use of the Alcohol Use Disorders Identification Test (20).
Thirteen participants who completed the USS examination and 29
participants with blood-based liver data who were classified as hazard-
ous drinkers at both ages were excluded from this study. To be eligible for
inclusion in analyses of USS outcomes, participants had to have valid
data for USS-measured liver fat or liver stiffness and at least one measure
of dietary intake between ages 3 and 13 y of age (n = 1786). For analyses
of blood-based liver outcomes, participants were eligible for inclusion if
they had data for ALT, AST, or GGTand at least one measure of dietary
intake between ages 3 and 13 y (n = 3059).
Statistical analysis
Modeling dietary intake trajectories. As described in a previous
publication (21), individual trajectories of energy, total carbohydrate,
sugar, starch, total fat, monounsaturated fat, poly unsaturated fat,
saturated fat and total protein intake from ages 3–13 y were estimated
with the use of linear-spline multilevel models fitted in MLwiN v2.28
with the use of the Stata (StataCorp) command ‘‘runmlwin’’ (22, 23).
They were estimated for participants with at least one available food
diary or FFQ, under a missing-at-random assumption. Full model details
are available on request. Trajectories were used to predict the dietary
intake of each participant at ages 3, 7, and 13 y. Energy-adjusted
macronutrient intake was calculated by regressing predicted macronu-
trient intake on predicted energy intake at each age and taking the
residuals from this regression. When assessing associations between
energy-adjusted macronutrient intake and liver outcomes, we further
adjusted for energy intake in all regression models (24).
Associations between dietary intake and liver outcomes. Regres-
sion analyses were conducted in Stata v12.0. All continuous outcomes
were positively skewed; their ln values were used in regression analyses
to ensure residuals were normally distributed. Predicted dietary intake at
ages 3, 7, and 13 y were related to continuous outcomes with the use of
linear regression, and to the binary USS-measured liver fat variable with
the use of logistic regression. Coefficients from regression models
including logged variables were back-transformed and are interpreted as
a percentage change.
Associations were examined in the following models: 1) unadjusted,
2) adjusted for potential confounders, and 3) additionally adjusted for
DXA-determined fat mass, height, and height squared at mean age
17.8 y to determine whether this attenuated any observed associations.
Likelihood ratio tests were used to check for gender interactions in all
regression analyses.
984 Anderson et al.
 at G
LASG
O
W
 UNIVERSITY on July 3, 2015
jn.nutrition.org
D
ow
nloaded from
 
Dealing with missing data and additional analyses. One-third of
eligible participants with USS data (594 of 1786), and 27% of eligible
participants with blood-based liver outcomes (821 of 3059) had missing
data for potential confounders and/or outcomes. Missing data for any
one characteristic varied from 0.03–13% (Supplemental Tables 1 and 2).
To minimize selection bias and increase efficiency, multivariate multiple
imputation was used to impute missing data for potential confounders
and outcomes for eligible participants. Full details of this procedure are
in Supplemental Methods. Details of a series of sensitivity analyses
conducted to verify model assumptions, test the robustness of our
findings, and explore whether associations between dietary intake at age
13 y and outcomes might have been confounded by physical activity or
pubertal stage are also provided in Supplemental Methods.
Results
The prevalence of USS-measured fatty liver was 2.5% in males
and females. An elevated ALT (>40 U/L) was noted in 4.3% of
males (63 of 1474) and 1.6% of females (26 of 1585). Variable
distributions were similar among imputed and observed datasets
(Supplemental Tables 1 and 2).
We present results with sexes combined; sex was adjusted for
in all regression models (P values for interaction with sex$0.1).
Results of the confounder-adjustedmodel (model 2) are presented
in Tables 1–6, with results from other models provided in
Supplemental Tables 3–6.
Associations between energy intake at ages 3, 7, and 13 y
and liver outcomes. Energy intake at age 3 y was positively
associated with USS-measured liver fat, ALT, and GGT. Energy
intake at age 7 y was positively associated with all liver outcomes
except AST. Energy intake at 13 y was positively associated with
ALT, AST, and GGT (Table 1).
Associations between absolute and energy-adjusted mac-
ronutrient intake at ages 3, 7, and 13 y and liver outcomes.
Associations between absolute and energy-adjusted carbohy-
drate, sugar, starch, protein, and fat intake at ages 3, 7, and 13 y
and USS- (n = 1786) and blood- (n = 3059) based liver outcomes
are presented in Tables 2–6, respectively. Associations between
saturated, monounsaturated and polyunsaturated fat and liver
outcomes are in the Supplemental Methods, because they were
much the same as those for total fat intake. Although we found
evidence of several positive associations between absolute
macronutrient intake at 3, 7, and 13 y and each of the USS-
and blood-based liver outcomes, there were no consistent
patterns, with the exception that energy intake and all absolute
macronutrient intake except sugar at ages 3, 7, and 13 y were
consistently positively associated with ALT.
After adjusting for energy intake, the majority of the
observed positive associations between absolute macronutrient
intake and outcomes attenuated to the null (including the
consistent positive associations between all macronutrient intake
at ages 3, 7, and 13 y and ALT). There were a few exceptions:
carbohydrate (Table 2), sugar (Table 3), and fat (Table 6)
intake at ages 3, 7, and 13 y all remained positively associated
with GGT; carbohydrate and fat intake at age 13 y remained
positively associated with AST; and starch (Table 4) and protein
(Table 5) intake at age 13 y remained positively associated with
ALT.
Mediation by fat mass at the time of liver outcome
assessment. After additional adjustment for fat mass at the
time liver outcomes were assessed, the majority (49 of 54) of
associations between energy intake and absolute macronutrient
intake and the USS- and blood-based liver outcomes attenuated
toward the null, although some (21) positive associations
remained. Most associations between energy-adjusted macro-
nutrient intake and the USS- and blood-based liver outcomes
also attenuated toward the null, except that associations
between energy-adjusted macronutrients and GGT remained
largely unchanged (model 3, Supplemental Tables 3–6).
Sensitivity analyses. Results were similar when restricting to
plausible reporters of dietary intake (Supplemental Table 7) and
when restricting to participants with 1) complete data on all
variables (Supplemental Table 8), 2) at least 2 measures of
dietary intake from 3–13 y (Supplemental Table 9), and 3) a
measure of dietary intake in each linear-spline period (Supple-
mental Table 10). Results were similar if a bivariate multilevel
model was used instead of dietary intake residuals from a
univariate multilevel model in regression models (Supplemental
Table 11), except that CIs were substantially wider. This is
expected, given that the bivariate models account for the
individual-level dietary intake residuals being estimated and
not known. Results were also similar after additional adjustment
for Alcohol Use Disorders Identification Test scores (Supple-
mental Table 12), and pubertal status and physical activity at
age 13 y (Supplemental Table 13).
Discussion
In this study we assessed associations between energy intakes
and absolute and energy-adjusted total fat, mono- and polyun-
saturated fat, saturated fat, total carbohydrate, sugar, starch,
TABLE 1 Associations between energy intake at ages 3, 7, and
13 y and USS- and blood-based liver outcomes at mean age 17.8 y
in the imputed data1
Value P
USS-measured liver fat
3 y 1.79 (1.14, 2.79) 0.01
7 y 1.30 (1.06, 1.60) 0.01
13 y 1.12 (0.84, 1.49) 0.45
USS-measured liver stiffness
3 y 1 (0, 3) 0.15
7 y 1 (0, 1) 0.06
13 y 0 (21, 1) 0.43
ALT
3 y 7 (4,10) ,0.01
7 y 3 (2, 5) ,0.01
13 y 4 (2, 5) ,0.01
AST
3 y 1 (20, 3) 0.23
7 y 1 (0, 1) 0.09
13 y 1 (0, 2) 0.04
GGT
3 y 5 (2, 7) ,0.01
7 y 2 (0, 3) ,0.01
13 y 3 (0, 4) ,0.01
1 Values are ORs (95% CIs) for liver fat and % changes (95% CIs) for liver stiffness,
ALT, AST, and GGT. n = 1786 for USS-measured liver outcomes at all ages. n = 3059
for blood-based liver outcomes at all ages. Coefficients are per 100 kcal increase
in energy intake at ages 3, 7, and 13 y. Adjusted for sex, age at outcome assessment,
maternal prepregnancy BMI, maternal age, social class, maternal education, and
parity. ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT,
g-glutamyltransferase; USS, ultrasound scan.
Dietary intake through childhood and risk of NAFLD 985
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and total protein intake at ages 3, 7, and 13 y and measures of
liver health in late adolescence. Because we excluded partici-
pants with hazardous alcohol consumption in the 12 mo before
liver assessment, and results did not change with further
adjustment for alcohol consumption, and because no partici-
pants had known hepatic disorders or were on medications that
would affect liver function, the associations observed are likely
to reflect those of childhood diet with adolescent NAFLD.
Energy intake in childhood and early adolescence was
consistently positively associated with markers of NAFLD, but
was not associated with liver stiffness. Associations between
absolute macronutrient intakes and liver outcomes were incon-
sistent. There was no evidence that a particular macronutrient
was most strongly associated with liver outcomes, or that intake
at a particular age was most strongly associated with liver
outcomes. However, all absolute macronutrient intake, as well
as energy intake, at ages 3, 7, and 13 y were consistently
positively associated with ALT. After adjusting for energy
intake, the majority of the observed positive associations
between absolute macronutrient intake and ALT (and other
liver outcomes with positive associations) attenuated to the null.
These results suggest that higher energy intake in childhood and
early adolescence is associated with greater NAFLD risk, and
that the relative proportions of macronutrients from which
energy intake is derived are less important. We found some
evidence to suggest that fat mass at the time of liver outcome
assessment in part mediates the association between childhood
dietary intake and NAFLD, with most associations between
energy and absolute macronutrient intakes and liver outcomes
attenuating toward the null upon adjustment for fat mass.
In a previous study with the use of data from the same cohort,
we found that the proportion of participants classified as under-
or over-reporters of energy intake increased from 15% at age 3 y
to 63% at age 13 y (21). This is perhaps due to the fact that
measurement error in dietary intake increases strongly with age,
as children begin completing food diaries themselves and eating
away from home more often. We attempted to account for this
potential source of bias when modeling the trajectories of
dietary intake by adjusting for a plausibility of reporting ratio,
which has been described in detail elsewhere (21). We also
checked results after restricting analyses to participants classified
as plausible reporters at ages 3, 7, and 13 y, and they were
similar to the main results. This provides some support that
implausible reporting of dietary intake does not substantially
bias our main results.
Comparison with findings from other studies. We found
energy intake in childhood and adolescence to be consistently
positively associated with markers of NAFLD, which contra-
dicts findings from studies reporting no associations between
energy intake and USS-identified NAFLD (9, 10), ALT, and AST
(11). We found absolute fat intake to be positively associated
with ALT; however, this was not associated with any other liver
TABLE 2 Associations between absolute and energy-adjusted
carbohydrate intake at ages 3, 7, and 13 y and USS- and blood-
based liver outcomes at mean age 17.8 y in the imputed data1
Absolute carbohydrate
intake
Energy-adjusted carbohydrate
intake
Value P Value P
USS-measured
liver fat
3 y 1.38 (1.06, 1.80) 0.02 1.12 (0.68, 1.84) 0.66
7 y 1.21 (1.04, 1.41) 0.01 1.10 (0.8, 1.52) 0.54
13 y 0.96 (0.82, 1.13) 0.63 0.88 (0.66, 1.17) 0.39
USS-measured
liver stiffness
3 y 1 (0, 1) 0.19 1 (21, 2) 0.52
7 y 1 (0, 1) 0.04 0 (21, 1) 0.51
13 y 0 (0, 1) 0.26 1 (0, 2) 0.13
ALT
3 y 3 (2, 5) ,0.01 21 (23, 2) 0.62
7 y 2 (0, 3) ,0.01 0 (22, 2) 0.89
13 y 2 (0, 3) ,0.01 1 (21, 2) 0.43
AST
3 y 1 (0, 2) 0.23 1 (21, 2) 0.49
7 y 1 (0, 1) 0.02 1 (0, 2) 0.13
13 y 1 (0, 1) ,0.01 1 (0, 2) 0.01
GGT
3 y 3 (2, 4) ,0.01 2 (0, 5) 0.03
7 y 2 (0, 2) ,0.01 2 (0, 3) 0.01
13 y 2 (0, 2) ,0.01 2 (1, 3) ,0.01
1 Values are ORs (95% CIs) for liver fat and % changes (95% CIs) for liver stiffness,
ALT, AST, and GGT. n = 1786 for USS-measured liver outcomes at all ages. n = 3059
for blood-based liver outcomes at all ages. Coefficients are per 100 kcal increase in
energy intake at ages 3, 7, and 13 y. Adjusted for sex, age at outcome assessment,
maternal prepregnancy BMI, maternal age, social class, maternal education, and
parity. ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT,
g-glutamyltransferase; USS, ultrasound scan.
TABLE 3 Associations between absolute and energy-adjusted
sugar intake at ages 3, 7, and 13 y and USS- and blood-based liver
outcomes at mean age 17.8 y in the imputed data1
Absolute sugar intake Energy-adjusted sugar intake
Value P Value P
USS-measured
liver fat
3 y 1.44 (1.02, 2.04) 0.04 1.26 (0.80, 1.98) 0.32
7 y 1.23 (0.99, 1.53) 0.06 1.12 (0.85, 1.47) 0.43
13 y 0.96 (0.79, 1.17) 0.67 0.96 (0.77, 1.22) 0.76
USS-measured
liver stiffness
3 y 1 (0, 2) 0.20 1 (21, 2) 0.28
7 y 0 (0, 1) 0.18 0 (21, 1) 0.51
13 y 0 (0, 1) 0.70 0 (21, 1) 0.74
ALT
3 y 2 (0, 4) 0.06 21 (24, 1) 0.26
7 y 1 (0, 2) 0.05 21 (22, 0) 0.16
13 y 0 (21, 1) 0.36 21 (22, 0) 0.06
AST
3 y 0 (21, 1) 0.74 0 (22, 1) 0.89
7 y 1 (0, 1) 0.15 0 (21, 1) 0.53
13 y 1 (0, 1) 0.02 1 (0, 1) 0.17
GGT
3 y 4 (2, 5) ,0.01 3 (1, 5) ,0.01
7 y 2 (0, 3) ,0.01 2 (1, 3) ,0.01
13 y 2 (0, 2) ,0.01 1 (0, 2) 0.02
1 Values are ORs (95% CIs) for liver fat and % changes (95% CIs) for liver stiffness,
ALT, AST, and GGT. n = 1786 for USS-measured liver outcomes at all ages. n = 3059
for blood-based liver outcomes at all ages. Coefficients are per 100 kcal increase in
energy intake at ages 3, 7, and 13 y. Adjusted for sex, age at outcome assessment,
maternal prepregnancy BMI, maternal age, social class, maternal education, and
parity. ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT,
g-glutamyltransferase; USS, ultrasound scan.
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outcomes and the associations attenuated to the null after
adjustment for energy intake. Consistent with this finding, 2
cross-sectional studies found absolute fat intake to be similar in
children with absent, mild, and moderate to severe NAFLD (9,
10), 1 study found no difference in percentage fat intake by ALT
status (11), and another study reported no significant differences
between children with steatosis compared with steatohepatitis for
fraction of energy from fat (12). Published results for subgroups of
fat intakes are conflicting: one study found that absolute SFA
intake proportionally increasedwith the degree of hepatic steatosis
(9); a second found a high percentage of saturated and a low
percentage of polyunsaturated fat intake in children with NAFLD
(8); a third found an inverse association between saturated fat
intake and NAFLD after adjusting for age, gender, and energy
intake (10), and a fourth found no association between percentage
total fat or saturated fat intake and steatosis grade (12). These
studies were all cross-sectional; to our knowledge, ours is the first
large prospective study to relate repeatedly assessed fat and fat
subcategories in childhood and early adolescence to NAFLD in
adolescence. Taken together, these findings do not provide strong
evidence for an effect from dietary fat intake in childhood on
subsequent NAFLD risk. However, we would suggest that
additional large prospective studies would be useful to clarify this.
Similar to our findings, one study reported no difference in
percentage carbohydrate intake between children with differing
severities of NAFLD (12), and another found no difference in
percentage carbohydrate intake by ALT status (11). Hattar et al.
(25) found no difference in the consumption of sweetened
beverages between those with NAFLD and the obese and lean
control groups. However, high carbohydrate intake and, more
specifically, high fructose and sucrose intake have been reported
cross-sectionally in children with existing NAFLD (8–10). No
studies to date have observed associations between protein
intake (absolute or percentage) and liver outcomes. Further large
prospective studies are required to clarify associations between
macronutrient intake and risk of NAFLD.
Whereas energy intake at all ages was positively associated
with most markers of NAFLD, this was not the case for liver
stiffness. This could indicate that childhood energy intake affects
the likelihood of liver fat accumulation but not liver fibrosis, or
that our measure of liver stiffness is not variable enough for us to
clearly detect associations in this study. Althoughwe are not aware
of other studies with the detailed data that we have to explore this,
it is necessary to assess these associations in additional large
prospective studies to see if they confirm our findings.
Strengths and limitations. Although power for the binary
outcome of USS-measured liver fat was limited because of the
small number of cases, we looked at a range of related outcomes
including ALT. The USS has a reported sensitivity of 85–90%
and specificity of 70–85% for detecting liver fat of at least 10%
but lower sensitivity and specificity for lower concentrations of
fat (9). Thus, our prevalence estimate most likely reflects the
prevalence for the more moderate to severe end of the disease
spectrum and consequently our results may be underestimated.
Importantly, a recent meta-analysis including 49 different
TABLE 4 Associations between absolute and energy-adjusted
starch intake at ages 3, 7, and 13 y and USS- and blood-based liver
outcomes at mean age 17.8 y in the imputed data1
Absolute starch intake Energy-adjusted starch intake
Value P Value P
USS-measured
liver fat
3 y 1.24 (0.86, 1.8) 0.25 0.90 (0.59, 1.38) 0.64
7 y 1.14 (0.90, 1.43) 0.28 0.93 (0.66, 1.3) 0.66
13 y 1.06 (0.79, 1.43) 0.70 0.95 (0.68, 1.33) 0.76
USS-measured
liver stiffness
3 y 0 (21, 2) 0.50 0 (21, 1) 0.75
7 y 1 (0, 1) 0.13 0 (21, 1) 0.75
13 y 1 (0, 2) 0.06 1 (0, 2) 0.09
ALT
3 y 4 (2, 6) ,0.01 1 (21, 3) 0.37
7 y 3 (2, 4) ,0.01 1 (0, 3) 0.09
13 y 5 (3, 6) ,0.01 3 (1, 5) ,0.01
AST
3 y 1 (21, 2) 0.33 1 (21, 2) 0.43
7 y 1 (0, 1) 0.11 0 (21, 2) 0.40
13 y 1 (0, 2) 0.03 1 (0, 2) 0.19
GGT
3 y 1 (21, 3) 0.24 21 (23, 1) 0.17
7 y 1 (0, 2) 0.09 21 (22, 1) 0.36
13 y 2 (0, 3) 0.02 0 (21, 2) 0.55
1 Values are ORs (95% CIs) for liver fat and % changes (95% CIs) for liver stiffness,
ALT, AST, and GGT. n = 1786 for USS-measured liver outcomes at all ages. n = 3059
for blood-based liver outcomes at all ages. Coefficients are per 100 kcal increase in
energy intake at ages 3, 7, and 13 y. Adjusted for sex, age at outcome assessment,
maternal prepregnancy BMI, maternal age, social class, maternal education, and
parity. ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT,
g-glutamyltransferase; USS, ultrasound scan.
TABLE 5 Associations between absolute and energy-adjusted
protein intake at ages 3, 7, and 13 y and USS- and blood-based
liver outcomes at mean age 17.8 y in the imputed data1
Absolute protein intake Energy-adjusted protein intake
Value P Value P
USS-measured
liver fat
3 y 2.60 (1.18, 5.73) 0.02 1.48 (0.59, 3.73) 0.41
7 y 1.75 (1.12, 2.75) 0.02 1.39 (0.74, 2.61) 0.31
13 y 1.68 (1.02, 2.77) 0.04 1.79 (0.93, 3.46) 0.08
USS-measured
liver stiffness
3 y 0 (23, 2) 0.75 22 (25, 1) 0.11
7 y 0 (20, 2) 0.80 21 (23, 0) 0.14
13 y 0 (22, 1) 0.57 21 (23, 0) 0.13
ALT
3 y 9 (4, 13) ,0.01 2 (23, 6) 0.53
7 y 6 (3, 8) ,0.01 2 (21, 6) 0.14
13 y 6 (4, 9) ,0.01 3 (0, 7) 0.04
AST
3 y 1 (22, 3) 0.60 0 (23, 3) 0.92
7 y 1 (20, 2) 0.36 0 (22, 2) 0.78
13 y 1 (20, 3) 0.30 0 (22, 2) 0.75
GGT
3 y 5 (0, 8) 0.01 0 (24, 4) 0.93
7 y 3 (0, 5) ,0.01 5 (22, 12) 0.20
13 y 4 (2, 6) ,0.01 5 (21, 13) 0.12
1 Values are ORs (95% CIs) for liver fat and % changes (95% CIs) for liver stiffness,
ALT, AST, and GGT. n = 1786 for USS-measured liver outcomes at all ages. n = 3059
for blood-based liver outcomes at all ages. Coefficients are per 100 kcal increase in
energy intake at ages 3, 7, and 13 y. Adjusted for sex, age at outcome assessment,
maternal prepregnancy BMI, maternal age, social class, maternal education, and
parity. ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT,
g-glutamyltransferase; USS, ultrasound scan.
Dietary intake through childhood and risk of NAFLD 987
 at G
LASG
O
W
 UNIVERSITY on July 3, 2015
jn.nutrition.org
D
ow
nloaded from
 
studies found the USS to be reliable and accurate for the
detection of steatosis compared with liver histology (26). The
missing-at-random assumption underlying multilevel models is
likely to hold in our example, because results were similar when
restricting analyses to participants with at least 2 dietary intake
measures and at least 1 measure in each linear-spline period.
FFQs in this study had no portion size information included;
hence, the intakes derived from these may be inaccurate (19).
However, we have previously shown that multilevel modeling
can be used to efficiently and validly combine data from FFQs
and food diaries in this cohort (21). In models in which we adjust
for potential mediation by fat mass outcome assessment, there
is a potential for collider bias (27). Adjusting for a potential
mediator can introduce residual confounding between the
exposure and the outcomes if there are unadjusted confounders
of the mediator-outcome relation. There is evidence that this
generally does not result in considerable bias in practice (28). In
this study, the only plausible confounder of the fat mass-NAFLD
association not already included in our confounder adjusted
regression models was physical activity. We conducted a sensitiv-
ity analysis in which we additionally adjusted associations for
objectively measured physical activity at age 13 y, and results were
very similar to those without adjustment. This cohort consisted
largely of white Europeans (97%); thus, our results may not
necessarily generalize to other ethnicities.
In conclusion, we have shown that higher childhood and
early adolescent energy intake is associated with greater NAFLD
risk, and that the macronutrients from which the energy is
derived are less important. These associations may be mediated
through general adiposity. If these findings are replicated in
other prospective studies, they highlight the importance of
ensuring healthy energy intake in childhood and adolescence for
the prevention of NAFLD.
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